comparemela.com

Drug Testing Index News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel

Xylazine found in 1 in 12 specimens tested, finds new Drug Misuse in America Health Trends® report on the rising polysubstance crisis SECAUCUS, N.J., Dec. 19, 2023 /PRNewswire/ Quest.

United statesDrug misuse in america health trendsUs centers for diseaseQuest diagnosticsHealth trendsQuest diagnostics health trendsDrug misuseAmerica health trendsGrowing crisisNovel psychoactive substancesDisease controlAbout quest diagnostics health trendsDiagnostics health trendsDrug testing index

One in Two Patients Tested Misuse Prescription Drugs, Finds 10th Annual Quest Diagnostics Health Trends® Report

/PRNewswire/ Today, Quest Diagnostics (NYSE: DGX) released its latest Health Trends® report, "Drug Misuse in America 2022: A Decade Lost to the Drug.

United statesJeffrey gudinHarveyw kaufmanUs centers for diseaseHealth trendsQuest diagnosticsQuest diagnostics health trendsDecade lostDrug crisisQuest diagnostics newsroomQuest diagnostics healthSenior medical directorHealth trends research programSenior medical advisorDrug monitoringDisease control

Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds

/PRNewswire/ More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nation s leading causes of cancer.

United statesHarveyw kaufmanYuri feskoFitch ratingsAmerican society of clinical oncologyNational institutes of cancerAmerican association for cancer researchHealth systemsQuest diagnosticsQuest diagnostics health trendsHealth trendsQuest diagnostics healthClinical oncologyClinical cancer informaticsAmerican societyCancer diagnoses still lagging

Breast and Prostate Cancer Diagnoses Still Lagging During Second Full Year of COVID-19 Pandemic, Quest Diagnostics Health Trends® Study Finds

/PRNewswire/ More than two years after the COVID-19 pandemic began, diagnoses of breast and prostate cancer, two of the nation s leading causes of cancer.

United statesHarveyw kaufmanYuri feskoFitch ratingsAmerican society of clinical oncologyNational institutes of cancerAmerican association for cancer researchHealth systemsQuest diagnosticsQuest diagnostics health trendsHealth trendsQuest diagnostics healthClinical oncologyClinical cancer informaticsAmerican societyCancer diagnoses still lagging

Quest Diagnostics Aims to Close Gaps in Maternal Healthcare with New Obstetrics Test Panel that Includes Hepatitis C Screening

/PRNewswire/ Quest Diagnostics (NYSE: DGX), the world s leading provider of diagnostic information services, today announced the launch of a new obstetrics.

United statesDamian pat alagiaHarveyw kaufmanJ clin gastroenterol hepatolUnited states preventative services taskWomen healthUs preventative services taskSociety of maternalAmerican college of obstetriciansQuest diagnosticsQuest diagnostics health trendsHealth trendsOur health trendsQuest diagnosticSenior medical directorHealth trends research program

vimarsana © 2020. All Rights Reserved.